These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30707172)
1. Progress of small ubiquitin-related modifiers in kidney diseases. Li O; Ma Q; Li F; Cai GY; Chen XM; Hong Q Chin Med J (Engl); 2019 Feb; 132(4):466-473. PubMed ID: 30707172 [TBL] [Abstract][Full Text] [Related]
2. Deciphering the SUMO code in the kidney. Yang Z; Zhang Y; Sun S J Cell Mol Med; 2019 Feb; 23(2):711-719. PubMed ID: 30506859 [TBL] [Abstract][Full Text] [Related]
3. High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells. Huang W; Xu L; Zhou X; Gao C; Yang M; Chen G; Zhu J; Jiang L; Gan H; Gou F; Feng H; Peng J; Xu Y Biochem Biophys Res Commun; 2013 Aug; 438(3):568-74. PubMed ID: 23911785 [TBL] [Abstract][Full Text] [Related]
4. SUMOylation occurs in acute kidney injury and plays a cytoprotective role. Guo C; Wei Q; Su Y; Dong Z Biochim Biophys Acta; 2015 Mar; 1852(3):482-9. PubMed ID: 25533125 [TBL] [Abstract][Full Text] [Related]
5. Exploring potential targets for natural product therapy of DN: the role of SUMOylation. Wang J; Zhang R; Wu C; Wang L; Liu P; Li P Front Pharmacol; 2024; 15():1432724. PubMed ID: 39431155 [TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178 [TBL] [Abstract][Full Text] [Related]
8. SUMO and SUMOylation Pathway at the Forefront of Host Immune Response. K ST; Joshi G; Arya P; Mahajan V; Chaturvedi A; Mishra RK Front Cell Dev Biol; 2021; 9():681057. PubMed ID: 34336833 [TBL] [Abstract][Full Text] [Related]
9. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. Yuan H; Lu Y; Chan YT; Zhang C; Wang N; Feng Y Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830854 [TBL] [Abstract][Full Text] [Related]
10. The post-translational modification, SUMOylation, and cancer (Review). Han ZJ; Feng YH; Gu BH; Li YM; Chen H Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374 [TBL] [Abstract][Full Text] [Related]
11. SUMO and the robustness of cancer. Seeler JS; Dejean A Nat Rev Cancer; 2017 Mar; 17(3):184-197. PubMed ID: 28134258 [TBL] [Abstract][Full Text] [Related]
12. The role of ubiquitination and sumoylation in diabetic nephropathy. Gao C; Huang W; Kanasaki K; Xu Y Biomed Res Int; 2014; 2014():160692. PubMed ID: 24991536 [TBL] [Abstract][Full Text] [Related]
13. The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease. Mendler L; Braun T; Müller S Circ Res; 2016 Jan; 118(1):132-44. PubMed ID: 26837744 [TBL] [Abstract][Full Text] [Related]
14. Sumoylation in liver disease. Zeng M; Liu W; Hu Y; Fu N Clin Chim Acta; 2020 Nov; 510():347-353. PubMed ID: 32710938 [TBL] [Abstract][Full Text] [Related]
15. Positive and negative regulation of APP amyloidogenesis by sumoylation. Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199 [TBL] [Abstract][Full Text] [Related]